Maa Suh-Hwa, Wang Chun-Hua, Liu Chien-Ying, Lin Horng-Chyuan, Huang Kuo-Hsiung, Kuo Han-Pin
School of Nursing, Chang Gung University, Taipei, Taiwan.
J Allergy Clin Immunol. 2003 Oct;112(4):761-7. doi: 10.1016/s0091-6749(03)02009-8.
Eosinophil apoptosis might play a crucial role in the maintenance of persistent airway inflammation in asthma. Nitric oxide (NO) synthase activity is upregulated in eosinophils of asthmatic patients. Mitogen-activated protein kinase (MAPK) is implicated in regulating eosinophil apoptosis by modulating Bcl-2 expression. NO-induced cell apoptosis is associated with an inhibition of Bcl-2 expression.
We sought to study whether NO might induce eosinophil apoptosis through extracellular signal-regulated protein kinase (ERK) or p38 MAPK pathways and Bcl-2 expression.
Eosinophils were freshly isolated from peripheral blood of 16 asthmatic patients and 12 healthy subjects and then cultured with or without the NO synthase inhibitor N-nitro-l-arginine methyl ester (L-NAME) at 1 and 10 mmol/L for 16 hours. The expression of Bcl-2 and induced NO synthase on eosinophils was analyzed by means of flow cytometry. Apoptosis was assessed by means of propidium iodide and DNA ladder. The activity of ERK and p38 MAPK was determined by means of Western blotting.
The induced NO synthase immunoreactivities and the spontaneous release of nitrite from the eosinophils of asthmatic patients were higher compared with those of healthy subjects. Eosinophils of asthmatic patients were found to express more highly constitutive Bcl-2 than those of healthy subjects. After incubation for 16 hours, the expression of Bcl-2 on eosinophils from patients with asthma was significantly enhanced by L-NAME. The percentage of apoptosis was decreased by the addition of 1 mmol/L L-NAME in patients with asthma. The activity of p38 MAPK and ERK in eosinophils from patients with asthma was enhanced in the presence of L-NAME. An inhibition of MAPK reduced the Bcl-2 expression and increased eosinophil apoptosis in patients with asthma.
We concluded that inhibition of endogenous NO might increase the expression of Bcl-2 in eosinophils from patients with asthma through the signaling pathway of ERK or p38 MAPK, which in turn decrease the apoptosis.
嗜酸性粒细胞凋亡可能在哮喘持续性气道炎症的维持中起关键作用。哮喘患者嗜酸性粒细胞中一氧化氮(NO)合酶活性上调。丝裂原活化蛋白激酶(MAPK)通过调节Bcl-2表达参与调控嗜酸性粒细胞凋亡。NO诱导的细胞凋亡与Bcl-2表达的抑制有关。
我们试图研究NO是否可能通过细胞外信号调节蛋白激酶(ERK)或p38 MAPK途径以及Bcl-2表达诱导嗜酸性粒细胞凋亡。
从16例哮喘患者和12名健康受试者的外周血中新鲜分离嗜酸性粒细胞,然后在有或无1和10 mmol/L的NO合酶抑制剂N-硝基-L-精氨酸甲酯(L-NAME)的情况下培养16小时。通过流式细胞术分析嗜酸性粒细胞上Bcl-2和诱导型NO合酶的表达。通过碘化丙啶和DNA梯带评估凋亡情况。通过蛋白质印迹法测定ERK和p38 MAPK的活性。
与健康受试者相比,哮喘患者嗜酸性粒细胞的诱导型NO合酶免疫反应性和亚硝酸盐的自发释放更高。发现哮喘患者的嗜酸性粒细胞比健康受试者表达更高水平的组成型Bcl-2。孵育16小时后,L-NAME显著增强了哮喘患者嗜酸性粒细胞上Bcl-2的表达。在哮喘患者中添加1 mmol/L L-NAME可降低凋亡百分比。在存在L-NAME的情况下,哮喘患者嗜酸性粒细胞中p38 MAPK和ERK的活性增强。MAPK的抑制降低了哮喘患者的Bcl-2表达并增加了嗜酸性粒细胞凋亡。
我们得出结论,抑制内源性NO可能通过ERK或p38 MAPK信号通路增加哮喘患者嗜酸性粒细胞中Bcl-2的表达,进而减少凋亡。